Closet is correct. NP should concentrate our limited resources where they will give a quick result. That is why NP has switched the emphasis from HIV to COVID with tremendous results over the past 4 months.Six months ago the share price was languishing at the one dollar range. Now after holding up to powerful and vicious attacks for 2 months the share price is still up about 300%. As a result of Dr P's brilliant work and NP's guidance the pandemic has propelled leronlimab into the forefront of therapeutics. Now we just have to be patient and support management against vicious attacks or nagging doubts.